Clinical Trial Update: A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Navicixizumab as monotherapy or in combination in patients with select advanced solid tumors, including colorectal cancer and triple-ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer
• Ovarian Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Navicixizumab (navicixizumab)

Snippet

Sponsor: OncXerna Theraputics, Inc. | Conditions: Colorectal Cancer, Triple Negative Breast Cancer | Phase 2 | Status: UNKNOWN